Utah - Idaho

Integrated Kidney Partners XX LLC

Primary Contact

 

Ryan Pardo
Ryan.Pardo@usrenalcare.com

 

KCE Participants

 

Dialysis Facilities

 

USRC OGDEN, LLC

 

Practices

 

IDAHO KIDNEY INSTITUTE LLP

AMANDA PRESTIGIACOMO  DENISE BARNES
 FAHIM RAHIM  HIRA SIKTEL
 JAHANGIR AHMED  JULIETTE HOLLINGSHEAD
 JUSTIN MERZLOCK  KHALED JANOM
 MICHAEL HADERLIE  NAEEM RAHIM
 NAGRAJ NARASIMHAN  NORA KIRKPATRICK
 TAREK BARBAR

UTAH KIDNEY INSTITUTE LLC

AMANDEEP CHADHA

UTAH KIDNEY CLINIC LLC

JAHANGIR AHMED  JAMES SHAFFNER
KRISTIE JONES  RYAN MCDONALD
TREVOR SMITH

INDEPENDENT PRACTITIONER 

GAUTHAM MOGILISHETTY

 

Preferred Providers

Practice Provider Name
TRANSTREME  RICK MICHEL
HEART CENTERED COUNSELING PC
PHC OF BUFFALO GROVE CLINICAL PSYCHOLOGY

 

Joint Ventures

 

There are no joint ventures between or among the KCE and any of its KCE Participant and Preferred Providers.

 

Administrative Lead

Name Employer
Mike Flood U.S. Renal Care

 

Clinical Lead

Name Employer
Dr. Danuta Trzebinska U.S. Renal Care

 

KCE Governing Body Members

Name Employer
Jahangir Ahmed  Utah Kidney Clinic LLC
Gautham Mogilishetty  Mogilishetty PLLC
Tarek Barbar  Idaho Kidney Institute LLP
Danuta Trzebinska  U.S. Renal Care
Mike Flood  U.S. Renal Care
Jerome Henry  U.S. Renal Care
Jenae Stout  U.S. Renal Care
Lori Hartwell  Consumer Advocate

 

Shared Savings and Shared Losses Information

 

a. The amount of any Shared Savings or Shared Losses for any Performance Year;
PY2023 Shared Savings will be reported in early 2024.

 

b. The proportion of Shared Savings invested in infrastructure, redesigned care processes, and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries; andPY2022 Shared Savings will be reported in early 2023.
PY2023 Shared Savings will be reported in early 2024.

 

c. Proportion of Shared Savings distributed to KCE Participants and Preferred Providers:
PY2023 Shared Savings will be reported in early 2024.

 

Quality Measure Performance

 

Quality Measure Performance for PY2023 will be reported in early 2024.